Cidara Therapeutics Inc Earnings

The next earnings date for Cidara Therapeutics Inc has not yet been scheduled.

Analyst Estimates of Cidara Therapeutics Inc Earnings

No Results.
Report DateEstimated Earnings Per Share
No Results.

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Cidara Therapeutics Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
04/21/2025After Market$-1.6652.20%
03/07/2025---$-5.38-46.49%
10/31/2024Before Market$-2.4542.35%
08/13/2024After Market$-19.99-520.81%
05/15/2024After Market$-2.28-1,040.00%
03/27/2024Before Market$-0.0460.00%
11/02/2023After Market$-0.0943.75%
08/03/2023After Market$-0.14-7.69%
05/11/2023After Market$0.03175.00%
03/23/2023Before Market$-0.19-11.76%
11/03/2022After Market$0.17-5.56%
08/09/2022After Market$-0.1932.14%
05/11/2022After Market$-0.276.90%
03/07/2022After Market$-0.2623.53%
11/10/2021After Market$-0.37-2.78%
08/12/2021After Market$0.18325.00%
05/13/2021After Market$-0.39-50.00%
02/25/2021After Market$-0.49-104.17%
11/05/2020After Market$-0.41-7.89%
08/13/2020After Market$-0.45-60.71%
05/13/2020After Market$-0.46-35.29%
03/04/2020Before Market$-0.422.33%
11/07/2019After Market$0.08130.77%
08/08/2019After Market$-0.4914.04%
05/09/2019After Market$-0.600.00%
02/28/2019After Market$-0.4425.42%
11/08/2018After Market$-0.4918.33%
08/08/2018After Market$-1.13-71.21%
05/10/2018After Market$-0.80-25.00%
02/27/2018After Market$-0.699.21%
11/08/2017After Market$-0.7322.34%
08/09/2017After Market$-0.99-12.50%
05/10/2017After Market$-0.809.09%
03/15/2017After Market$-0.88-11.39%
11/10/2016After Market$-0.880.00%
08/11/2016After Market$-0.85-11.84%
05/12/2016After Market$-0.714.05%
03/18/2016Before Market$-0.72-2.86%
11/16/2015After Market$-0.67-17.54%
08/11/2015After Market$-0.59-3.51%
05/21/2015After Market$-5.92-745.71%

More About Cidara Therapeutics Inc

Website
https://www.cidara.com
Country
USA
Full Time Employees
38

Cidara Therapeutics, Inc. operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company's product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also develops its Cloudbreak platform that enables development of novel drug-Fc conjugates, that includes CD388, a potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase 1 and Phase 2a clinical trials. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.

“Cidara Therapeutics Inc Earnings” Can Refer to the Cidara Therapeutics Inc Earnings Date

Some people say “Cidara Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Cidara Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Cidara Therapeutics Inc Stock on the Earnings Date

If you own Cidara Therapeutics Inc stock (CDTX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Cidara Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Cidara Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Cidara Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Cidara Therapeutics Inc earnings or anything else related to the stock market.